REGISTRATION RIGHTS AGREEMENT among NPS PHARMACEUTICALS, INC. as Issuer, and MORGAN STANLEY & CO. INCORPORATED and GOLDMAN, SACHS & CO., as Initial Purchasers Dated as of June 17, 2003Registration Rights Agreement • August 12th, 2003 • NPS Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
REGISTRATION RIGHTS AGREEMENT (this “Agreement”) dated as of June 17, 2003 between NPS Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Morgan Stanley & Co. Incorporated and Goldman, Sachs & Co., (the “Initial Purchasers”) pursuant to the Purchase Agreement dated June 11, 2003 (the “Purchase Agreement”), between the Company and the Initial Purchasers. In order to induce the Initial Purchasers to enter into the Purchase Agreement, the Company has agreed to provide the registration rights set forth in this Agreement. The execution of this Agreement is a condition to the closing under the Purchase Agreement.
